Paper319010
Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies.
Sensenbrenner LL and 2 others. Exp Hematol, 1977. Cited by 87 papers, by iCite.
Cite this record
ConductScience Library. Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies. Papers, record 319010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/319010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recovery of hematologic competence without engraftment following attempted bone marrow transplantation for aplastic anemia: Report of a case with diffusion chamber studies.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anemia, Aplastic | Major topic |
| Bone Marrow Cells | Major topic |
| Bone Marrow Transplantation | Major topic |
| Hematopoiesis | Major topic |
| Adolescent | |
| Blood Cell Count | |
| Bone Marrow | |
| Cells, Cultured | |
| Cyclophosphamide | |
| Erythroblasts | |
| Granulocytes | |
| Hepatitis | |
| Histiocytes | |
| Humans | |
| Immunosuppression Therapy | |
| Injections, Intravenous | |
| Karyotyping | |
| Lymphocytes | |
| Male | |
| Monocytes | |
| Transplantation, Homologous |
Source PubMed
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40438974 | Towards graft-versus-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia. | Haematologica | 2025 | https://conductscience.org/library/papers/40438974 | PubMed |
| 36435690 | The development of post-transplant cyclophosphamide: Half a century of translational team science. | Blood Rev | 2023 | https://conductscience.org/library/papers/36435690 | PubMed |
| 30047416 | Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia. | Hematol Oncol Clin North Am | 2018 | https://conductscience.org/library/papers/30047416 | PubMed |
| 28638379 | Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia. | Front Immunol | 2017 | https://conductscience.org/library/papers/28638379 | PubMed |
| 28228650 | Haematopoietic stem cell transplantation for autoimmune diseases. | Nat Rev Rheumatol | 2017 | https://conductscience.org/library/papers/28228650 | PubMed |
| 27467367 | High-dose Cyclophosphamide is Effective Therapy for Pediatric Severe Aplastic Anemia. | J Pediatr Hematol Oncol | 2016 | https://conductscience.org/library/papers/27467367 | PubMed |
| 21495931 | Clinical management of aplastic anemia. | Expert Rev Hematol | 2011 | https://conductscience.org/library/papers/21495931 | PubMed |
| 20087683 | High-dose cyclophosphamide for autoimmunity and alloimmunity. | Immunol Res | 2010 | https://conductscience.org/library/papers/20087683 | PubMed |
| 19786984 | Cyclophosphamide and cancer: golden anniversary. | Nat Rev Clin Oncol | 2009 | https://conductscience.org/library/papers/19786984 | PubMed |
| 18958751 | Intensive immunosuppression with high dose cyclophosphamide but without stem cell rescue for severe autoimmunity: advantages and disadvantages. | Autoimmunity | 2008 | https://conductscience.org/library/papers/18958751 | PubMed |
| 8485206 | Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor. | Ann Hematol | 1993 | https://conductscience.org/library/papers/8485206 | PubMed |
| 7000209 | Proceedings of the Annual Meeting of the European Foundation for Bone Marrow Transplantation, Sils Maria (Engadine), Switzerland, April 13-16, 1980. | Blut | 1980 | https://conductscience.org/library/papers/7000209 | PubMed |
| 6992565 | Genetic markers in human bone marrow transplantation. | Am J Hum Genet | 1980 | https://conductscience.org/library/papers/6992565 | PubMed |
| 6605326 | Complete remission of severe aplastic anaemia following treatment with anti-thymocyte globulin. | Ir J Med Sci | 1983 | https://conductscience.org/library/papers/6605326 | PubMed |
| 380689 | Successful allogeneic bone marrow retransplantation with the same donor after graft rejection: application of a modified conditioning regimen. | Blut | 1979 | https://conductscience.org/library/papers/380689 | PubMed |
| 312812 | Neutropenia in three patients with rheumatic disorders. Suppression of granulopoiesis by control-sensitive thymus-dependent lymphocytes. | J Clin Invest | 1979 | https://conductscience.org/library/papers/312812 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/319010
GET https://conductscience.org/api/papers/v1/319010/authors